powered to detect differences in efficacy, and the failure rates of the two POPs are not proven to be significantly different. In our unit we advise two (traditional) POPs per day in women under 45 years of age who weigh more than 70 kg, although this may not be necessary for women at low risk of pregnancy, such as those who are fully lactating. We also advise two POPs per day or the desogestrel-only pill for any woman who has had a 'true' contraceptive failure on the POP in the past. In view of the present case, the question arises of whether we can still trust the presumed, yet unproven, greater efficacy of the desogestrel-only pill. Anecdotally we know that some clinicians are advising two desogestrel-only pills a day for women heavier than 100 kg. Clearly there is a need to weigh up the risks and benefits in each individual woman's case and for a careful, documented discussion to take place.
In examining the available literature we find that Vessey and Painter explored oral contraceptives and body weight in a large cohort study. 3 They found that there was no statistical significance in the slightly higher rate of accidental pregnancies in the group on the POP weighing 82 kg or more. Their study did not, however, have enough power either to support the hypothesis that there was a higher failure rate in this group or disprove it.
We draw on evidence from studies undertaken in women using Norplant ® or the levonorgestrel-releasing vaginal ring. 4, 5 With regard to Norplant, the study showed a trend of increasing pregnancy rate and weight. 4 This was statistically significant for the early Norplant with the denser tubing. In Sivin's study, women weighing above 70 kg experienced the highest overall pregnancy rates. The results showed that the total gross cumulative pregnancy rate at 60 months was 0.2 per 100 for women weighing less than 50 kg in contrast to 7.6 per 100 for women over 70 kg. 4 Therefore, the findings of studies using Norplant suggest that a relationship between progestogen-only contraceptives and weight does exist but that studies to date using POPs have not been sufficiently large to detect this.
A World Health Organization study comprising 1005 women using the levonorgestrel-releasing vaginal ring also supports the relationship between increasing pregnancy rate and body weight. 5 In this study researchers found an estimated pregnancy rate of 1.7% for women weighing 40 kg and 9.8% for those weighing 80 kg. 5 On the basis of this evidence, the Clinical Effectiveness Unit (CEU) advised in 2003 that pending more evidence the two-pill regime may be more appropriate in young women. 6 This 2003 advice has now been superseded by the current POP guidance document 1 mentioned earlier, which advises one pill per day. It is not surprising that this change in advice represents a common area of confusion in clinical practice, especially for non-specialists.
So far as the present case is concerned, after the woman's second POP failure the recommendation was a change to a long-acting reversible contraceptive (LARC) method, the most reliable option. However, if a woman wishes for a progestogen-only oral contraceptive method then the question remains should a double dose of pill be prescribed? Is a double dose less risky than an unintended pregnancy in a heavy woman? There remain a lot of unanswered questions and a lack of conclusive data. Also the studies to date tend to base their data on weight; however, this is not the same as BMI. A woman over 6 feet tall may well weigh more than 70 kg. Does this make a difference? Trussell et al. 7 have recently highlighted the limitations in obtaining reliable data, for example, when based on patients' self-reported pill adherence. With the growing incidence of obesity, the need for conclusive guidance becomes increasingly relevant and vital. We would suggest that in the absence of definite evidence it is safer for heavier women to take two POPs than risk an unintended pregnancy. However, we would welcome more evidence on this issue, and indeed some evidence specifically relating to Cerazette. In 2009, 94% of abortions were funded by the NHS; of these over half (60%) took place in the independent sector under NHS contract. In 2002, 78% of abortions were funded by the NHS; of these just over a third took place in the independent sector under NHS contract.
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Contraception in the BNF
Ann Furedi, Chief Executive of the British Pregnancy Advisory Service (BPAS), said of the new statistics: "It's interesting to see that fewer abortions took place last year, for the second year running. We're really pleased that a greater proportion of abortions took place at the earliest stages in 2009. There has been a 2% rise in the number of under 10 weeks' abortions, which now make up three quarters of all abortions. In fact, 91% of all abortions were carried out at under 13 weeks of pregnancy. This probably indicates that better NHS funding has helped to build in more of the capacity needed to care for women when they need it. Unintended pregnancy and abortion will always be facts of life, because women want to make sure the time is right for them to take on the important role of becoming a parent. Abortion statistics are reflective of women's very serious consideration regarding that significant role within their current situation." Source: www.dh.gov.uk The Pleasure Principle FPA is offering a fresh new course for professionals called 'The Pleasure Principle', which explores how to carry out safe, educational work with young people around pleasure. Young people tell us, as part of their Sex and Relationships Education (SRE), they would like less factual information and more about forming positive partnerships and getting the most from an intimate relationship. The Pleasure Principle aims to explore how to support young people to have positive and enjoyable sexual relationships that can fit into conversations about risk and enable young people to feel more engaged with sexual health messages.
Professionals can expect discussions around promoting sex relationships, exploration into personal and professional attitudes to sexpositive work, exploration of sex-positive approaches to group work with young people, and communication about safer sex with young people in a sex-positive manner. For more details contact Helen Shipley (e-mail: Helens@fpa.org) or see the advertisement on page 184 of this issue.
Mifepristone for intermenstrual bleeding with the LNG-IUS
A group of researchers in New Delhi have studied the effects of mifepristone on intermenstrual bleeding in levonorgestrel-releasing intrauterine system (LNG-IUS) users. Thirty-six women using LNG-IUS for menorrhagia received 100 mg mifepristone every 30 days for 3 months (Group 1). Fifty age-matched LNG-IUS users receiving no mifepristone were the control group (Group 2). At 3 months, median duration and episodes of intermenstrual bleeding/spotting were significantly lower in Group 1 compared with Group 2 (6 vs 12.5 days, p = 0.01; 2.5 vs 3, p = 0.05, respectively). More women were satisfied with the LNG-IUS in the mifepristone group compared with the control group (75% vs 44%, p = 0.004). The effect was similar at 6 months. The researchers have concluded that mifepristone was effective in reducing the number of episodes and duration of intermenstrual bleeding/spotting in LNG-IUS users. 
Social networking sites blamed for increase in syphilis
Professor Peter Kelly, Director of Public Health for NHS Tees, said the biggest cause of spreading this serious disease was unprotected sex. He blames the use of social networking sites for casual sex on the four-fold rise in the number of cases of syphilis in heterosexuals in his area. More young women are being affected. In pregnancy syphilis can lead to miscarriage, stillbirth or disability. Professor Kelly warned people using the Internet to find sex to protect themselves. Symptoms depend on the development of the disease, and at first many sufferers are unaware of any problem. Nationally, the highest rates of syphilis are seen in women aged 20-24 years and men aged 25-34 years. In 2008 there were 3588 cases of syphilis diagnosed in sexual health clinics across the UK.
